ACRF Chemical Biology

ACRF Chemical Biology

Protein structure formed in the process of apoptosis
The ACRF Chemical Biology division investigates key biological processes and pathways critical in disease development to discover potential drug targets important for human disease.
Our researchers use chemical, biochemical, structural and biological approaches to establish how dysregulation of critical cell signalling pathways contributes to disease, and use this to guide novel therapeutic development.

Health impact

Cancers: blood cancers, breast cancers, gastric, stomach cancerlung cancer, ovarian cancer, pancreatic cancermyeloproliferative disorders

Immune disorders: Crohn’s disease, inflammatory bowel disease, multiple sclerosis, psoriasis, sepsis, asthmarheumatic fever and heart disease

Infectious disease: HIV, malaria, toxoplasmosis and vaccines

Other areas: heart disease and stroke, neurodegenerative disease, personalised medicine, thalassemia

Division news

Division head

Associate Professor Guillaume Lessene

Lab heads

Associate Professor Chris Burns, visiting scientist

Associate Professor Ethan Goddard-Borger

Associate Professor Isabelle Lucet

Dr Brad Sleebs

Professor Keith Watson, honorary

Division coordinator

Leeanne Lewis